13F filer · CIK 1214717 ↗
Geode Capital Management, LLC
You are looking at Q2 2022. See the latest, Q2 2026 →
Reported value
$682.64B
−15% on the quarter before
Positions
5,015
170 new · 130 sold out
Top 10
22.6%
of the value
Est. gain
−$132.49B
on stocks held all quarter
Est. return
−16.7%
on those stocks since Q1 2022
Positions as of Jun 30, 2022, from Geode Capital Management, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 34% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.
Largest buys
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$902.7MAdded · 5.1% → 5.1%+3,520,660 shares
- Apple~$842.6MAdded · 5.9% → 5.6%+6,174,524 shares
- Warner Bros Discovery Inc~$614.8MNew · 0.0% → 0.1%+45,891,072 shares
- Home Depot Inc~$580.2MAdded · 0.6% → 0.8%+2,118,982 shares
- Alphabet~$348.6MAdded · 1.9% → 1.8%+160,265 shares
- American Tower~$337.7MAdded · 0.3% → 0.4%+1,323,278 shares
- Vici Properties Inc~$329.7MAdded · 0.0% → 0.1%+11,082,678 shares
- Johnson & Johnson~$298.7MAdded · 1.0% → 1.2%+1,685,961 shares
- Tesla~$277.2MAdded · 1.9% → 1.5%+412,426 shares
- Chevron Corp~$269.3MAdded · 0.7% → 0.7%+1,862,987 shares
Largest sells
Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Cerner Corp~$600.2MSold out · 0.1% → 0.0%−6,428,613 shares
- Amazon~$382.3MCut · 3.0% → 2.4%−3,607,130 shares
- Peoples United Financial Inc~$169.0MSold out · 0.0% → 0.0%−8,467,059 shares
- Marathon Petroleum Corp~$157.5MCut · 0.1% → 0.1%−1,920,443 shares
- S&P Global Inc~$153.8MCut · 0.3% → 0.3%−457,124 shares
- Discovery Inc-C~$150.8MSold out · 0.0% → 0.0%−6,055,291 shares
- Aspen Technology Inc~$150.1MSold out · 0.0% → 0.0%−906,289 shares
- Zynga Inc - Cl A~$130.4MSold out · 0.0% → 0.0%−14,113,197 shares
- Palo Alto Networks~$123.4MCut · 0.1% → 0.1%−250,262 shares
- Anaplan Inc~$119.4MSold out · 0.0% → 0.0%−1,836,072 shares
Holdings
As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +2.3% · price −21.6% | 5.6% | $37.97B | −$10.26B | ||||||||
| MicrosoftCOM · shares +2.6% · price −16.6% | 5.1% | $35.11B | −$6.83B | ||||||||
| AmazonCOM · shares −2.3% · price −31.5% | 2.4% | $16.11B | −$7.42B | ||||||||
| AlphabetCAP STK CL A · shares +2.9% · price −21.6% | 1.8% | $12.31B | −$3.29B | ||||||||
| AlphabetCAP STK CL C · shares +1.9% · price −21.6% | 1.6% | $10.61B | −$2.87B | ||||||||
| TeslaCOM · shares +2.9% · price −37.5% | 1.5% | $9.91B | −$5.77B | ||||||||
| Berkshire Hathaway Inc-Cl BCL B NEW · shares +1.7% · price −22.6% | 1.2% | $8.42B | −$2.42B | ||||||||
| Unitedhealth Group IncCOM · shares +2.8% · price +0.8% | 1.2% | $8.38B | +$64.2M | ||||||||
| Johnson & JohnsonCOM · shares +3.7% · price +0.2% | 1.2% | $8.28B | +$18.5M | ||||||||
| MetaCL A · shares +2.9% · price −27.4% | 1.0% | $6.87B | −$2.52B | ||||||||
| NvidiaCOM · shares +2.6% · price −44.4% | 0.99% | $6.74B | −$5.24B | ||||||||
| Procter & Gamble Co/TheCOM · shares +3.7% · price −5.8% | 0.96% | $6.55B | −$391.3M | ||||||||
| Exxon Mobil CorpCOM · shares +3.7% · price +3.8% | 0.93% | $6.33B | +$222.5M | ||||||||
| Visa Inc.COM CL A · shares +2.6% · price −11.2% | 0.89% | $6.11B | −$747.8M | ||||||||
| Pfizer IncCOM · shares +3.5% · price +1.3% | 0.83% | $5.68B | +$72.8M | ||||||||
| Jpmorgan Chase & CoCOM · shares +1.4% · price −17.3% | 0.81% | $5.53B | −$1.14B | ||||||||
| Home Depot IncCOM · shares +12% · price −8.3% | 0.78% | $5.32B | −$428.7M | ||||||||
| Eli LillyCOM · shares +2.6% · price +13.3% | 0.75% | $5.09B | +$581.5M | ||||||||
| Chevron CorpCOM · shares +5.6% · price −11.0% | 0.74% | $5.05B | −$592.2M | ||||||||
| MastercardCL A · shares +1.9% · price −11.7% | 0.73% | $4.95B | −$641.5M | ||||||||
| Coca-Cola Co/TheCOM · shares +4.2% · price +1.5% | 0.68% | $4.61B | +$67.2M | ||||||||
| Abbvie IncCOM · shares +4.7% · price −5.4% | 0.67% | $4.60B | −$252.8M | ||||||||
| Merck & Co. Inc.COM · shares +3.6% · price +11.2% | 0.61% | $4.19B | +$407.0M | ||||||||
| Pepsico IncCOM · shares +3.7% · price −0.4% | 0.61% | $4.13B | −$14.4M | ||||||||
| Verizon Communications IncCOM · shares +3.4% · price −0.3% | 0.58% | $3.94B | −$11.6M | ||||||||
| Total · 5,015 positions | 100% | $682.64B | −$132.49B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2022 to Q2 2022: 4,843 stocks held throughout, down $132.49B (−16.7%).
- Eli Lilly+$581.5M+13%
- Merck & Co. Inc.+$407.0M+11%
- Exxon Mobil Corp+$222.5M+4%
- IBM+$172.3M+9%
- Bristol-Myers Squibb Co+$150.9M+6%
- Nvidia−$5.24B−44%
- Tesla−$5.77B−37%
- Microsoft−$6.83B−17%
- Amazon21:1 split−$7.42B−32%
- Apple−$10.26B−22%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 30 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.88T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.61T−1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $1.62T+3% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $1.57T+10% | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | $1.43T+12% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $1.27T−1% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.29T+5% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $1.23T+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $1.14T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.08T+13% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $955.85B+14% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $839.58B−1% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $850.99B+11% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $770.08B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $712.57B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $659.25B−3% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $682.64B−15% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $801.12B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $830.26B+12% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $742.82B+2% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $725.80B+11% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $653.80B+10% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $595.80B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $510.36B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $467.44B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $383.70B−60% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 (amended) | $956.78B+123% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $428.50B+4% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $413.26B+7% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $385.96B−40% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $646.86B+82% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $354.88B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $325.29B+6% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $306.93B+4% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $294.47B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.92B+7% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $254.31B+4% | SEC ↗ |
| Q1 2017 | Jun 21, 2017 (amended) | $243.78B+13% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $215.04B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $198.58B+8% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $183.87B−2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $188.44B | SEC ↗ |